Beximco Pharmaceuticals (LSE:BXP) Institutional Ownership: 1.07% (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:BXP Beximco Pharmaceuticals PLC LSE:BXP
63 GF Score
Price £0.52
GF Value £0.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Beximco Pharmaceuticals Institutional Ownership?

Beximco Pharmaceuticals LSE:BXP 63 Institutional Ownership is 1.07% as of Aug. 03, 2026. GuruFocus rates LSE:BXP with a GF Score™ of 63/100 and a GF Value™ of £0.49 (Fairly Valued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Beximco Pharmaceuticals's institutional ownership is 1.07%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Beximco Pharmaceuticals's Insider Ownership is 4.20%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Beximco Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.

Beximco Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Beximco Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals Institutional Ownership Chart

Beximco Pharmaceuticals Historical Data

The historical data trend for Beximco Pharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.29 0.29 0.29 0.29 0.29 0.29 0.29 0.29 0.29 1.07
LSE:BXP
63GF Score
Beximco Pharmaceuticals PLC LSE:BXP
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beximco Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.07% mean?
Beximco Pharmaceuticals (LSE:BXP) has a Institutional Ownership of 1.07% as of Aug. 03, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Beximco Pharmaceuticals and its competitors.
Is Beximco Pharmaceuticals' Institutional Ownership too high?
Beximco Pharmaceuticals' current Institutional Ownership is 1.07%. Overall, Beximco Pharmaceuticals has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' Institutional Ownership compare to ZTS and UTHR?
Beximco Pharmaceuticals' Institutional Ownership of 1.07% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Beximco Pharmaceuticals and its competitors. Beximco Pharmaceuticals's current Institutional Ownership is 1.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Beximco Pharmaceuticals (LSE:BXP) is currently considered Fairly Valued. The stock's GF Value™ is £0.49, compared to a current price of £0.52 — trading 5.1% above its estimated fair value. The current Institutional Ownership is 1.07%. Beximco Pharmaceuticals' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Beximco Pharmaceuticals (LSE:BXP), the current Institutional Ownership is 1.07% as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beximco Pharmaceuticals (LSE:BXP) Overvalued in 2026?

Based on GuruFocus' analysis, Beximco Pharmaceuticals stock appears to be overvalued. The current stock price of £0.52 is trading 5.1% above its estimated GF Value™ of £0.49. GuruFocus considers Beximco Pharmaceuticals to be Fairly Valued.

Key valuation signals for LSE:BXP:

  • Institutional Ownership: 1.07%
  • GF Value™: £0.49 vs. price of £0.52 (5.1% above fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the LSE:BXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beximco Pharmaceuticals Business Description

Address 19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.
63GF Score

Get the complete analysis for LSE:BXP

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.52
Price
£0.49
GF Value